Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Premier African Minerals announces new Zulu resource estimate

(Sharecast News) - Premier African Minerals announced an update to its Zulu lithium and tantalum project on Friday, with the release of a new SAMREC-compliant mineral resource estimate, replacing the previous estimate issued in June 2017. The AIM-traded firm said the new MRE was focussed on areas within the Zulu tenements expected to be mined and processed through the current plant, excluding the broader EPO area.

It estimated that the lithium oxide contained in spodumene amounts to 107,366 tonnes, with a direct conversion of the lithium oxide to spodumene concentrate 6 (SC6) totalling 1,789,433 tonnes.

Additionally, the MRE identified the presence of 1,045,908 kilograms of tantalum pentoxide within the ore body.

"This MRE supports the development of the Zulu mine on an expedited basis," said chief executive officer George Roach.

"It underlines our confidence in the medium and long-term future of this mine and further supports our view that Zulu has the stand-alone potential to develop a lithium sulphate plant.

"Work continues in the greater EPO area, and we have now identified areas of future potential mineralisation and secured those areas in the longer term under new mineral claims."

At 1055 GMT, shares in Premier African Minerals were down 9.72% at 0.33p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.